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Abstract: Reliable and accurate detection of carbapenemase-
producing enterobacteria (CPE) is based on both non-molecular
(phenotypic) and molecular methods. The obvious ﬁrst step is
recognition of carbapenem resistance using clinical breakpoints
(EUCAST/CLSI); however, as some susceptible enterobacteria can
still produce a carbapenemase, screening criteria (as deﬁned by
EUCAST), whole pattern of -lactam resistance and simultaneous
resistance to other families should also be considered. Care should
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be taken when using automatic methods, which may produce false
susceptibility results for CPE.
Metallo--lactamases (MBL, Class B) do not hydrolyze
monobactams, while OXA-48-like (O48L, Class D) enzymes
cause resistance to temocillin and piperacillin-tazobactam and
are poorly active against expanded-spectrum cephalosporins.
Importantly, CPE may also produce other -lactamases (i.e.,
extended-spectrum -lactamases, ESBL), which determine very
complex phenotypic patterns. KPC (Class A) carbapenemases are
inhibited by boronic acid derivatives, while MBL are inhibited
by EDTA, 1,10-phenanthroline, thiol compounds and dipicolinic
acid. Comparison of zones around discs of carbapenems (usually
meropenem) alone or with the indicated inhibitors will sug-
gest the presence of a certain carbapenemase class, and help to
exclude other mechanisms of carbapenem resistance (i.e. porin
loss plus AmpC/ESBL production). Other smart approaches have
also been designed based on the inhibition activity of the indicated
compounds.
Detection of carbapenemases can be made demonstrating their
hydrolytic activity against carbapenems using bioassays (several
variants of the modiﬁed Hodge test or the so-called carbapenem
inhibition method), colorimetric assays (Carba NP and Carba Blue),
MALDI-Tof or spectrophotometry. Immunochromatography assays
(including commercial versions for some enzymes) have been
designed for IMP-, OXA- and KPC-type carbapenemases. Recently,
an electrochemical device (BYG carba test) has been designed for
rapid carbapenemase detection.
Carbapenemase-producing Enterobacteria can be selectively
cultured using carbapenem-containing media. Clinical samples
can be pre-incubated in a liquid medium with a commercial
carbapenem disk, then subcultured on MacConkey agar with
imipenem or on any of the multiple version of the commer-
cially available chromogenicmedia (ChromID variants, Supercarba,
CHROMagarKPC,HardyCHROMCarbapenemase,BrillianceCRE. . .).
Once bacteria have grown, carbapenemase can be detected using
phenotypic or molecular methods.
Every laboratory should decide about themore convenient algo-
rithm for detecting CPE, taking into account the incubation time
needed for methods based on culture (including bioassays and disc
approaches), the usefulness of rapid methods (such as colorimet-
ric assays, MALDI-Tof or immunochromatography) and the need of
molecular assays for deﬁnitive identiﬁcation of concrete enzymes.
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Abstract: The gold standard for diagnostics of infectious dis-
eases and detection of antibiotic resistant organisms are culture
and antibiotic susceptibility testing respectively. However, culture
is sometimes unsuccessful because patients have been treatedwith
antibiotics or are infected with unculturable or difﬁcult to culture
microorganisms.
Antigen detection using an imunochromatographical technique
is a simple and rapid method that has been used for the diagnosis
of infectious diseases such as Legionnaires’ disease, pneumococcal
infection, and Mycoplasma pneumonia. We have already con-
structed system for detecting carbapenemases in Acinetobacter
spp. such as the OXA-23 group, OXA-24/40 group, OXA-51 group
and OXA-58 group. However, this system is not able to detect car-
bapenemases directly from clinical specimens.
Multiplex PCR is a useful technique for active surveillance or
targeted surveillance of carbapenemase encoding genes in Enter-
obacteriaceae. However, novel or mutated carbapenemase genes
cannot detect by PCR.
On the other hand, next generation sequencing (NGS) is a pow-
erful tool for the diagnosis of infectious diseases and enables
a comprehensive search for antibiotic resistant genes. Whole
genome sequence (WGS) data or Meta genome sequence (MGS)
data is provided frombacterial colonyor clinical specimens, respec-
tively.
In this presentation, I will discuss novel techniques for the diag-
nosis of infectious diseases causing by carbapenemase producing
infections.
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Abstract: Given that treatment options for carbapenem-
resistant enterics is limited, we should concentrate our efforts on
prevention methods. These preventative interventions are usually
combined into a bundle of interventions and include: increased
handhygiene compliance, active surveillance cultures, contact pre-
cautions, cohorting patients and hospital personnel, heightened
environmental disinfection, limiting communal objects, and antibi-
otic stewardship. During this session we will review the most
relevant papers on this topic and the most recent literature.
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